D
Design Therapeutics, Inc. DSGN
$6.22 -$0.50-7.38% NASDAQ
Recommendation
Prev Close
$6.71
Volume
71,625
Avg Vol (90D)
150,490
Market Cap
$382.12M
Dividend & Yield
--
52-Week Range
$2.60 - $7.77
P/E (TTM)
--
EPS (TTM)
-$1.12
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
The volume for Design Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 447% of the 65-Day Volume Moving Average
10/16/2025 - Tickeron - Technical Analysis
Design Therapeutics (DSGN, $6.49) entered Downtrend as Momentum indicator drops below 0 level on Oct 13, 2025
10/14/2025 - Tickeron - Technical Analysis
Design Therapeutics (DSGN, $6.75) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 10, 2025
10/11/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $7.12) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 9, 2025
10/10/2025 - Tickeron - Stocks
Design Therapeutics (NASDAQ:DSGN) Given "Sell (D-)" Rating at Weiss Ratings
10/10/2025 - MarketBeat
Design Therapeutics (DSGN, $6.11) entered Uptrend as Momentum indicator ascends above 0 level on Oct 03, 2025
10/4/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.02) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 2, 2025
10/3/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.02) entered Downtrend as Momentum indicator drops below 0 level on Oct 02, 2025
10/3/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.79) RSI Indicator left the overbought zone on October 01, 2025
10/2/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $7.53) RSI Indicator left the overbought zone on September 30, 2025
10/1/2025 - Tickeron - Stocks
Design Therapeutics Reaches Analyst Target Price
10/1/2025 - ETF Channel
Design Therapeutics (DSGN, $6.85) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 29, 2025
9/30/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.85) price may drop as it broke higher Bollinger Band on Sep 29, 2025
9/30/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.44) entered Uptrend as Momentum indicator ascends above 0 level on Sep 24, 2025
9/25/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.02) entered Downtrend as Momentum indicator drops below 0 level on Sep 23, 2025
9/24/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.35) entered Uptrend as Momentum indicator ascends above 0 level on Sep 22, 2025
9/23/2025 - Tickeron - Technical Analysis
Design Therapeutics (DSGN, $6.06) entered Downtrend as Momentum indicator drops below 0 level on Sep 19, 2025
9/20/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.25) entered Uptrend as Momentum indicator ascends above 0 level on Sep 18, 2025
9/19/2025 - Tickeron - Stocks
Design Therapeutics (DSGN, $6.03) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 12, 2025
9/13/2025 - Tickeron - Stocks
Design Therapeutics Appoints Justin Gover to Board of Directors
9/10/2025 - GuruFocus
Design Therapeutics Appoints Justin Gover as Director
9/10/2025 - TipRanks Financial Blog
Design Therapeutics Appoints Justin Gover to Board of Directors
9/10/2025 - Globe Newswire
Design Therapeutics (DSGN, $5.82) RSI Indicator left the overbought zone on September 08, 2025
9/9/2025 - Tickeron - Stocks
Almitas Capital LLC Acquires 129,229 Shares of Design Therapeutics, Inc. $DSGN
9/5/2025 - MarketBeat
Design Therapeutics, Inc. (DSGN) Presents at Cantor Global Healthcare Conference 2025 Transcript
9/5/2025 - SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$74.31M
EBIT (TTM)
-$74.93M
Net Income (TTM)
-$63.49M
Balance Sheet
Total Assets (Q)
$222.89M
Total Debt (Q)
$1.95M
Total Liabilities (Q)
$9.85M
Book Value Per Share (Q)
$3.74
Cash Flow
Cash from Operations (TTM)
-$50.64M
Cash from Investing (TTM)
$23.99M
Cash from Financing (TTM)
$648.00K
Net Change in Cash (TTM)
-$26.00M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
1.90
7-Day Total Return
-4.31%
30-Day Total Return
1.64%
60-Day Total Return
45.43%
90-Day Total Return
58.82%
Year to Date Total Return
0.65%
1-Year Total Return
9.91%
2-Year Total Return
184.86%
3-Year Total Return
-61.04%
5-Year Total Return
--
52-week Low
Apr 11, 2025 - $2.60
52-week High
Nov 13, 2024 - $7.77
Valuation
Market Cap
$382.12M - Small Cap
Enterprise Value
$167.79M
Price/Sales (TTM)
--
Price/Book (Q)
1.79
Dividends and Shares
Shares Outstanding
56.86
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.designtx.com
Phone Number
858 293 4900
Address
6005 Hidden Valley Road
Carlsbad, CA 92011
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the... more
NASDAQ 10/16/2025 3:53PM Eastern Quotes delayed